<P>Technetium-99m-labeled human serum albumin (<SUP>99m</SUP>Tc-HSA) has been utilized as a blood pool imaging agent in the clinic for several decades. However, <SUP>99m</SUP>Tc-HSA has a short circulation time, which is ...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A107459657
2019
-
SCIE,SCOPUS
학술저널
1586-1595(10쪽)
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
<P>Technetium-99m-labeled human serum albumin (<SUP>99m</SUP>Tc-HSA) has been utilized as a blood pool imaging agent in the clinic for several decades. However, <SUP>99m</SUP>Tc-HSA has a short circulation time, which is ...
<P>Technetium-99m-labeled human serum albumin (<SUP>99m</SUP>Tc-HSA) has been utilized as a blood pool imaging agent in the clinic for several decades. However, <SUP>99m</SUP>Tc-HSA has a short circulation time, which is a critical shortcoming for a blood pool imaging agent. Herein, we developed a novel <SUP>99m</SUP>Tc-labeled HSA with a long circulation time using click chemistry and a chelator, 2,2′-dipicolylamine (DPA), (<SUP>99m</SUP>Tc-DPA-HSA). Specifically, we examined the feasibility of copper-free strain-promoted alkyne-azide cycloaddition (SPAAC) for the incorporation of HSA to the [<SUP>99m</SUP>Tc (CO)<SUB>3</SUB>(H<SUB>2</SUB>O)<SUB>3</SUB>]<SUP>+</SUP> system by adopting a chelate-then-click approach. In this strategy, a potent chelate system, azide-functionalized DPA, was first complexed with [<SUP>99m</SUP>Tc (CO)<SUB>3</SUB>(H<SUB>2</SUB>O)<SUB>3</SUB>]<SUP>+</SUP>, followed by the SPAAC click reaction with azadibenzocyclooctyne-functionalized HSA (ADIBO-HSA) under biocompatible conditions. Radiolabeling efficiency of azide-functionalized DPA (<SUP>99m</SUP>Tc-DPA) was >98%. Click conjugation efficiency of <SUP>99m</SUP>Tc-DPA with ADIBO-HSA was between 76 and 99% depending on the number of ADIBO moieties attached to HSA. In whole-body in vivo single photon emission computed tomography images, the blood pool uptakes of <SUP>99m</SUP>Tc-DPA-HSA were significantly enhanced compared to those of <SUP>99m</SUP>Tc-HSA at 10 min, 2, and 6 h after the injection (<I>P</I> < 0.001, 0.025, and 0.003, respectively). Furthermore, the blood activities of <SUP>99m</SUP>Tc-DPA-HSA were 8 times higher at 30 min and 10 times higher at 3 h after the injection compared to those of conventional <SUP>99m</SUP>Tc-HSA in ex vivo biodistribution experiment. The results exhibit the potential of <SUP>99m</SUP>Tc-DPA-HSA as a blood pool imaging agent and further illustrate the promise of the pre-labeling SPAAC approach for conjugation of heat-sensitive biological targeting vectors with [<SUP>99m</SUP>Tc (CO)<SUB>3</SUB>(H<SUB>2</SUB>O)<SUB>3</SUB>]<SUP>+</SUP>.</P>
[FIG OMISSION]</BR>